摘要
70%以上的男性不育病因不明,即使在已知病因的男性不育中,其发病机制尚未完全阐明,因此男性不育诊治有其复杂性与特殊性。自从1992年发明卵细胞胞质内单精子注射(ICSI)治疗男性不育以来,对难治性男性不育取得突破性进展,但对每一男性不育个体选择治疗时,传统治疗方法应受到重视。男性不育诊治程序的规范化、辅助生殖技术的成功率和安全性等研究将成为男性不育发展的主导方向。
Exact etiological factors cannot be found in more than 70% of male infertility. Although the causes of some male infertility are known, the pathogenesis is not yet clear. Therefore, the diagnosis and treatment of male infertility are particularly complicated. Some breakthroughs have been made in the treatment of refractory male infertility since the development of ICSI in 1992. However, traditional treatment should also be taken into account for individual male infertility. The standardization of diagnosis and treatment and the improvement of the success rate and safety of assistant reproductive technology will be the dominant factors in the development of male infertility researches.
出处
《中华男科学杂志》
CAS
CSCD
2006年第9期771-774,共4页
National Journal of Andrology
